Page 93 - 南京医科大学自然版

第45卷第3期 顾天昊，李沣员，徐 皓. 肌脂肪变性作为胃肠道间质瘤患者的新预后因素［J］.
2025年3月 南京医科大学学报（自然科学版），2025，45（3）：373-381，388 ·381 ·

Conflict of Interests： Cachexia Sarcopenia Muscle，2018，9（2）：326-334
The authors declared no potential conflict of interests. ［11］HOPKINS J J，REIF R，BIGAM D，et al. Change in skele⁃
作者贡献声明： tal muscle following resection of stage Ⅰ ⁃ Ⅲ colorectal
顾天昊负责数据管理、形式分析、验证、调查、可视化、方 cancer is predictive of poor survival：a cohort study［J］.
法论、撰写初稿、撰写审阅和编辑。李沣员负责资源、软件。 World J Surg，2019，43（10）：2518-2526
徐皓负责概念化、资金获取、项目管理、监督。 ［12］MILJKOVIC I，ZMUDA J M. Epidemiology of myosteato⁃
Author’s Contributions： sis［J］. Curr Opin Clin Nutr Metab Care，2010，13（3）：
GU Tianhao was responsible for data curation，formal analy⁃ 260-264
sis，validation，investigation，visualization，methodology，writing⁃ ［13］REINDERS I，MURPHY R A，KOSTER A，et al. Muscle
original draft，writing ⁃ review and editing. LI Fengyuan was quality and muscle fat infiltration in relation to incident
responsible for resources，software. XU Hao was responsible for mobility disability and gait speed decline：the age，gene/
conceptualization，funding acquisition，project administration， environment susceptibility⁃Reykjavik study［J］. J Geron⁃
and supervision. tol A Biol Sci Med Sci，2015，70（8）：1030-1036
［参考文献］ ［14］HONG S，KIM K W，PARK H J，et al. Impact of baseline
muscle mass and myosteatosis on the development of early
［1］ BLAY J Y，KANG Y K，NISHIDA T，et al. Gastrointesti⁃
toxicity during first ⁃ line chemotherapy in patients with
nal stromal tumours［J］. Nat Rev Dis Primers，2021，7
initially metastatic pancreatic cancer［J］. Front Oncol，
（1）：22
2022，12：878472
［2］ CASALI P G，ABECASSIS N，ARO H T，et al. Gastroin⁃
［15］JAFRI S H R，PREVIGLIANO C，KHANDELWAL K，
testinal stromal tumours：ESMO⁃EURACAN clinical prac⁃
et al. Cachexia index in advanced non ⁃ small ⁃ cell lung
tice guidelines for diagnosis，treatment and follow⁃up［J］.
cancer patients［J］. Clin Med Insights Oncol，2015，9：87-
Ann Oncol，2018，29（suppl 4）：iv68-iv78
93
［3］ SØREIDE K，SANDVIK O M，SØREIDE J A，et al. Global
epidemiology of gastrointestinal stromal tumours（GIST）： ［16］GOH M J，KANG W，JEONG W K，et al. Prognostic
significance of Cachexia index in patients with advanced
a systematic review of population⁃based cohort studies［J］.
hepatocellular carcinoma treated with systemic chemo⁃
Cancer Epidemiol，2016，40：39-46
therapy［J］. Sci Rep，2022，12（1）：7647
［4］ XU L，MA Y P，WANG S F，et al. Incidence of gastrointes⁃
［17］SERRANO C，MARTÍN⁃BROTO J，ASENCIO⁃PASCUAL
tinal stromal tumor in Chinese urban population：a national
population⁃based study［J］. Cancer Med，2021，10（2）： J M，et al. 2023 GEIS Guidelines for gastrointestinal
stromal tumors［J］. Ther Adv Med Oncol，2023，15：
737-744
17588359231192388
［5］ CIOFFI A，MAKI R G. GI stromal tumors：15 years of les⁃
sons from a rare cancer［J］. J Clin Oncol，2015，33（16）： ［18］MOURTZAKIS M，PRADO C M M，LIEFFERS J R，et al.
A practical and precise approach to quantification of body
1849-1854
［6］ VON MEHREN M，JOENSUU H. Gastrointestinal stromal composition in cancer patients using computed tomogra⁃
tumors［J］. J Clin Oncol，2018，36（2）：136-143 phy images acquired during routine care［J］. Appl Physiol
［7］ HEMMING M L，HEINRICH M C，BAUER S，et al. Trans⁃ Nutr Metab，2008，33（5）：997-1006
lational insights into gastrointestinal stromal tumor and ［19］LIN G T，HUANG J B，LIN J L，et al. Body composition
current clinical advances［J］. Ann Oncol，2018，29（10）： parameters for predicting the efficacy of neoadjuvant
2037-2045 chemotherapy with immunotherapy for gastric cancer［J］.
［8］ DEV R，BRUERA E，DALAL S. Insulin resistance and Front Immunol，2022，13：1061044
body composition in cancer patients［J］. Ann Oncol， ［20］PRADO C M M，LIEFFERS J R，MCCARGAR L J，et al.
2018，29（suppl 2）：ii18-ii26 Prevalence and clinical implications of sarcopenic obesity
［9］ LOU N，CHI C H，CHEN X D，et al. Sarcopenia in over⁃ in patients with solid tumours of the respiratory and
weight and obese patients is a predictive factor for postoper⁃ gastrointestinal tracts：a population⁃based study［J］. Lancet
ative complication in gastric cancer：a prospective study［J］. Oncol，2008，9（7）：629-635
Eur J Surg Oncol，2017，43（1）：188-195 ［21］CUSHEN S J，POWER D G，TEO M Y，et al. Body compo⁃
［10］CHOI M H，YOON S B，LEE K，et al. Preoperative sarco⁃ sition by computed tomography as a predictor of toxicity
penia and post⁃operative accelerated muscle loss negatively in patients with renal cell carcinoma treated with suni⁃
impact survival after resection of pancreatic cancer［J］. J （下转第388页）